NCT03300466View on ClinicalTrials.gov

A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

April 24, 2019

Conditions
Nasolabial FoldSafety
Interventions
DEVICE

GP0045

Hyaluronic acid gel

DEVICE

Comparator

Hyaluronic acid gel

Trial Locations (1)

Unknown

Q-Med, Uppsala

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT03300466 - A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds | Biotech Hunter | Biotech Hunter